Agios Pharmaceuticals, Inc.
AGIONASDAQHealthcare● Active
$27.44
$-0.85(-3.00%)
Market Cap$1.6B
P/E Ratio—
52W High$46
52W Low$22.24
Agios Pharmaceuticals, Inc.（AGIO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AGIO · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $54.03M | $36.50M | $26.82M | $14.24M | $0.00M |
| Cost of Revenue | $11.52M | $4.17M | $9.50M | $1.70M | $18.78M |
| Gross Profit | $42.51M | $32.33M | $17.32M | $12.54M | ($18.78M) |
| Gross Margin %(computed) | 78.67% | 88.59% | 64.57% | 88.03% | — |
| Operating Expenses | |||||
| R&D Expenses | $334.36M | $301.29M | $288.90M | $279.91M | $256.97M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $514.64M | $458.07M | $408.81M | $401.58M | $359.64M |
| Operating Income | ($472.13M) | ($425.74M) | ($391.49M) | ($389.05M) | ($378.42M) |
| Operating Margin %(computed) | -873.87% | — | — | — | — |
| Interest Income | $56.38M | $48.08M | $33.34M | $12.79M | $0.84M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($413.80M) | $717.97M | ($352.09M) | ($231.80M) | ($356.51M) |
| Income Tax Expense | ($1.02M) | $44.24M | $0.00M | $0.00M | $0.00M |
| Net Income | ($412.78M) | $673.73M | ($352.09M) | ($231.80M) | $1604.71M |
| Net Margin %(computed) | -764.01% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-7.12 | $11.86 | $-6.33 | $-4.23 | $-6.36 |
| Wtd Avg Shares | 57.97M | 56.81M | 55.65M | 54.79M | 60.45M |
| EBITDA | ($466.95M) | ($420.08M) | ($384.86M) | ($380.48M) | ($337.73M) |
| EBITDA Margin %(computed) | -864.28% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Agios Pharmaceuticals, Inc.
关于Agios Pharmaceuticals, Inc.（AGIO）损益表
Agios Pharmaceuticals, Inc.（AGIO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，AGIO实现营收$0.05B，毛利润$0.04B（毛利率78.67%），净利润($0.41B)（净利率-764.01%）。
常见问题
AGIO · 4 问Agios Pharmaceuticals, Inc.（AGIO）2025财年营收为$0.05B，同比up48.0%。
AGIO revenueAGIO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08